Académique Documents
Professionnel Documents
Culture Documents
ANTIBIOTIC IN
ABDOMINAL SEPSIS
IBRAHIM AHMADSYAH
SCHOOL OF MEDICINE
UNIVERSITY OF INDONESIA
INTRA ABDOMINAL INFECTION
PERITONITIS
- PRIMARY
- SECONDARY
- TERTIARY
ABSCESS FORMATION
ORGAN /SPACE SURGICAL SITE
INFECTION (SSI)
PRIMARY PERITONITIS
Organ/Space SSI
Caused by predominantly by
anaerobes
Single drug therapy, Cephalosporin
with activity against anaerobes
Combination with anaerobic
coverage antibiotic(Metronidazole,
Clindamycine)
Extended-Spectrum -
Lactamases
Detected mainly in klebsiellae and E. coli
Recently described in P. mirabilis, C. freundii,
E. aerogenes
Confer resistance to 3rd & 4th generation
cephalosporins & aztreonam
Frequent co-resistance to quinolones and
aminoglycosides
Usually inhibitor susceptible
SENTRY Surveillance Program 1997-99
ESBL in E.coli
50
40
30
%
ESBL
20
10 8.5 7.9
4.2 5.3
0
US n=1203 Latin America Europe n=3822 Asia-Pacific
n=2026 n=1104
Clavulanic acid
Amoxicillin
Ticarcilin
Sulbactam
Ampicillin
Cefoperazone
Tazobactam
Piperacillin
Cefoperazone /Sulbactam
Clinical use
Hospital-acquired pneumonia
Intraabdominal infections
Obstetrical and gynecological infections
Pelviperitonitis
Pelvic abscess
Intrauterin infections
Febrile neutropenia
Nosocomial UTI
Noscomial skin & soft-tissue infections
Pediatric infections
Cefoperazone-Sulbactam vs Clindamycin +
Gentamicin in Intraabdominal Infections
100
Cef/Sulb
110/152 evaluable
80 * Clinda+Genta patients
Cef/Sulb 3 g bid
60
* Clinda 2400 mg/d +genta
% * p<0.006 4.5-6mg/kg day in 4
pts40 doses
20 336 aerobic isolates
91% suceptible to cef/sulb
0 85% to clinda + genta
Cured Imp Failed 112 anaerobes
95% suceptible to all 3
antibiotics
Jauregui LE, et al. JAC 1990;25:423-33
Cefoperazone-Sulbactam
in Biliary Infections
Open, prospective, multicenter trial
273/338 patients evaluable
127 cholecystitis
132 cholangitis
14 liver abscesses
93 patients (34%) had malignancy
Overall efficacy 80%
89%, cholecystitis In pts w malignancy, 63%
Surgical treatment
Subphrenic abscess 1
Subhepatic abscess 2
Acute Appendicitis
Periapp mass with abscess formation 2
Perforation 2
Total 31
ANTIBIOTIC TREATMENT
- 31 patients ( mean age: 49 yrs)
- Acute cholecystitis & acute appendicitis
- Antibiotic Sulbactam-Cefoperazon
- 2 gr before skin incision, daily dose 2 gr
in two doses
- Average duration of treatment 3 days
(range 2-5 days)
- Surgical site infection: nil
CONCLUSION
Combination of timely surgical intervention,
appropriate antibiotic therapy and normal host
defense mechanism result in complete resolution of
the infection and subsequent recovery
Antibiotic play an integral role in preparation of a
patient for operation
Administration of antibiotic that are active against
both aerobes and anaerobes is generally to be the
gold standard.Have to be cautious of ESBL in E.coli